newsfilter
← Latest News
PR Newswire·

BrainStorm Cell Therapeutics Granted Compliance Extension from Nasdaq

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company committed to the development and commercialization of best-in-class ...